This review highlights the risk factors, diagnosis, and management of DVT in pregnancy, emphasizing heparin and low molecular-weight heparin as the anticoagulants of choice.
No takes yet. Share an insight, caveat, or question.
Reinforces heparin and LMWH preference for VTE in pregnancy; leaves open optimal dosing and monitoring in prospective trials.
Stephanie Colman-Brochu (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: